Cocrystal Pharma COCP Q1 2026 Annual earnings
Reported May 15, 2026 · Before market open
Revenue$225.0KIn line
EPS-$0.17Miss by $0.02
Revenue estimate$225.0K
EPS estimate-$0.15
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$225.0K
EPS estimate-$0.17
Versus estimates
Revenue
Q1 2026$225.0KIn line
Q4 2024$136.0KDiluted EPS
Ask the moment Cocrystal Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Cocrystal Pharma report Q1 2026 earnings?
- Cocrystal Pharma (COCP) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were Cocrystal Pharma's Q1 2026 revenue and EPS?
- Cocrystal Pharma reported revenue of $225.0K and eps of $-0.17 for Q1 2026.
- Did Cocrystal Pharma beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $225.0K by -. EPS missed the consensus estimate of $-0.15 by $0.02.
- How did Cocrystal Pharma's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 26.1% from $-0.23.
- Where can I find Cocrystal Pharma's Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001493152-26-013838) directly on SEC EDGAR. The filing index links above go to sec.gov.